109
Views
1
CrossRef citations to date
0
Altmetric
Original Research

A Prospective, Comparative, Clinical Study to Evaluate the Safety and Efficacy of Two Different 0.1% Riboflavin Solutions Used in Collagen Crosslinking Treatment for Patients with Keratoconus

ORCID Icon, ORCID Icon, , &
Pages 2607-2617 | Published online: 21 Jun 2021

References

  • Wollensak G. Crosslinking treatment of progressive keratoconus: new hope. Curr Opin Ophthalmol. 2006;(17):356–360.
  • Wollensak G, Spoerl E, Seiler T. Riboflavin 0.1%/ultraviolet-a-induced collagen crosslinking for the treatment of Keratoconus. Am J Ophthalmol. 2003;135(5):620–627. doi:10.1016/S0002-9394(02)02220-1
  • Asri D, Touboul D, Fournié P, et al. Corneal collagen crosslinking in progressive keratoconus: multicenter results from the French National Reference Center for Keratoconus. J Cataract Refract Surg. 2011;37(12):2137–2143. doi:10.1016/j.jcrs.2011.08.026
  • Tan P, Mehta JS. Collagen crosslinking for keratoconus. J Ophthalmic Vis Res. 2011;6(3):153–154.
  • Li G, Fan ZJ, Peng XJ. Corneal collagen crosslinking for conical ectasia of post-LASIK: one-year results. Int J Ophthalmol. 2012;5(2):190–195. doi:10.3980/j.issn.2222-3959.2012.02.15
  • Derakhshon A, Shandiz JH, Ahadi M, Daneshvar R, Esmaily H. Short-term outcomes of collagen crosslinking for early keratoconus. J Ophthalmic Vis Res. 2011;6(3):155–159.
  • Agrawal V. Long-term results of cornea collagen crosslinking with Riboflavin 0.1% for Keratoconus. Indian J Ophthalmol. 2013;61(8):433–434.
  • Sachdev GS, Sachdev M, Recent advances in corneal collagen cross-linking. Indian J Ophthalmol. 2017;65:787–796. doi:10.4103/ijo.IJO_648_17
  • Goldich Y, Marcovich AL, Barkana Y, Avni I, Zadok D. Safety of corneal collagen cross-linking with UV-A and riboflavin in progressive keratoconus. Cornea. 2010;29(4):409–411. doi:10.1097/ICO.0b013e3181bd9f8c
  • Galvis V, Tello A, Ortiz AI, Escaf LC. Patient selection for corneal collagen cross-linking: an updated review. ClinOphthalmol. 2017;7(11):657–668.
  • Mohan RR, Stapleton WM, Sinha S, Netto MV, Wilson SE. A novel method for generating corneal haze in anterior stroma of the mouse eye with the excimer laser. Exp Eye Res. 2008;86(2):235–240. doi:10.1016/j.exer.2007.10.014
  • Jabbar A. Efficacy of corneal collagen crosslinking with riboflavin and ultraviolet a in progressive keratoconus. DJO. 2013;24(1):23–27. doi:10.7869/djo.2013.4
  • Gatzioufas Z, Richoz O, Brugnoli E, Hafezi F. Safety profile of high-fluence corneal collagen cross-linking for progressive keratoconus: preliminary results from a prospective cohort study. J Refract Surg. 2013;29(12):846–848. doi:10.3928/1081597X-20131023-03
  • Lanchares E, Angeles Del Buey M, Cristóbal JA, Lavilla L, Calvo B. Biomechanical property analysis after corneal collagen cross-linking in relation to ultraviolet A irradiation time, Graefes. Arch ClinExpOphthalmol. 2011;249:1223–1227.
  • Schumacher S, Mrochen M, Wernli J, Bueeler M, Seiler T. Optimization model for UV-riboflavin corneal cross-linking. Invest Ophthalmol Vis Sci. 2012;53(2):762–769. doi:10.1167/iovs.11-8059
  • Peyman A, Nouralishahi A, Hafezi F, Kling S, Peyman M. Stromal demarcation line in pulsed versus continuous light accelerated corneal cross-linking for keratoconus. J Refract Surg. 2016;32:206–208. doi:10.3928/1081597X-20160204-03
  • Kling S, Richoz O, Hammer A, et al. Increased biomechanical efficacy of corneal cross-linking in thin corneas due to higher oxygen availability. J Refract Surg. 2015;31:840–846. doi:10.3928/1081597X-20151111-08
  • Paningasan JL. Long-term effect on corneal curvature of corneal collagen cross-linking for keratoconus. Philipp J Ophthalmol. 2019;44(2).
  • Buzzonetti L, Petrocelli G. Transepithelial corneal cross-linking in pediatric patients: early results. J Refract Surg. 2012;28:763–767. doi:10.3928/1081597X-20121011-03
  • Shetty R, Nagaraja H, Jayadev C, et al. Accelerated corneal collagen cross-linking in pediatric patients: two-year follow-up results. Biomed Res Int. 2014;2014:894095.
  • Caporossi A, Mazzotta C, Baiocchi S, et al. Age-related long-term functional results after riboflavin UV a corneal crosslinking. J Ophthalmol. 2011;608041.
  • Kumar Kodavoor SK, Arsiwala AZ, Ramamurthy D. One-year clinicalstudy of efficacy of corneal collagen cross-linking in Indian children withprogressive keratoconus. Cornea. 2014;33:919–922. doi:10.1097/ICO.0000000000000197
  • Wollensak G, Iomdina E. Biomechanical and histological changes after corneal crosslinking with and without epithelial debridement. J Cataract Refract Surg. 2009;35:540–546. doi:10.1016/j.jcrs.2008.11.036
  • Sloot F, Soeters N, van der Valk R, et al. Effective corneal collagen crosslinking in advanced cases of progressive keratoconus. J Cataract Refract Surg. 2013;39:1141–1145. doi:10.1016/j.jcrs.2013.01.045
  • Caporossi A, Mazzotta C, Paradiso AL, et al. Transepithelial cornealcollagen crosslinking for progressive keratoconus: 24-month clinical results. J Cataract Refract Surg. 2013;39:1157–1163. doi:10.1016/j.jcrs.2013.03.026
  • Henriquez MA, Rodríguez AM, Izquierdo L Jr. Accelerated epi-on versus standard epi-off corneal collagen cross-linking for progressive keratoconus in pediatric patients. Cornea. 2017;36(12):1503–1508. doi:10.1097/ICO.0000000000001366
  • Gore DM, Shortt AJ, Allan BD. New clinical pathways for keratoconus. Eye (Lond). 2013;27(3):329–339. doi:10.1038/eye.2012.257
  • Rosenblat E, Hersh PS. Intraoperative corneal thickness change and clinical outcomes after corneal collagen crosslinking: standard crosslinking versus hypotonic riboflavin. J Cataract Refract Surg. 2016;42(4):596–605. doi:10.1016/j.jcrs.2016.01.040
  • Kymionis GD, Tsoulnaras KI, Liakopoulos DA, et al. Corneal stromal demarcation line depth following standard and a modified high intensity corneal cross-linking protocol. J Refract Surg. 2016;32:218–222. doi:10.3928/1081597X-20160216-01